BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30573685)

  • 21. Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.
    Lin W; Huang J; Liao X; Yuan Z; Feng S; Xie Y; Ma W
    Pharmacol Res; 2016 Sep; 111():849-858. PubMed ID: 27491559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
    Yamaguchi N; Nakayama Y; Yamaguchi N
    J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. eIF3f: a central regulator of the antagonism atrophy/hypertrophy in skeletal muscle.
    Sanchez AM; Csibi A; Raibon A; Docquier A; Lagirand-Cantaloube J; Leibovitch MP; Leibovitch SA; Bernardi H
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2158-62. PubMed ID: 23769948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
    De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
    BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer.
    Ribas R; Pancholi S; Rani A; Schuster E; Guest SK; Nikitorowicz-Buniak J; Simigdala N; Thornhill A; Avogadri-Connors F; Cutler RE; Lalani AS; Dowsett M; Johnston SR; Martin LA
    Breast Cancer Res; 2018 Jun; 20(1):44. PubMed ID: 29880014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors.
    Muthukaruppan A; Lasham A; Woad KJ; Black MA; Blenkiron C; Miller LD; Harris G; McCarthy N; Findlay MP; Shelling AN; Print CG
    Clin Breast Cancer; 2017 Apr; 17(2):139-153. PubMed ID: 27756582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential inhibitory potencies and mechanisms of the type I ribosome inactivating protein marmorin on estrogen receptor (ER)-positive and ER-negative breast cancer cells.
    Pan WL; Wong JH; Fang EF; Chan YS; Ye XJ; Ng TB
    Biochim Biophys Acta; 2013 May; 1833(5):987-96. PubMed ID: 23274857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells.
    Li Y; Jiang B; Wu X; Huang Q; Chen W; Zhu H; Qu X; Xie L; Ma X; Huang G
    Biochem Biophys Res Commun; 2018 Sep; 503(1):45-50. PubMed ID: 29792859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E; Prossnitz ER
    BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function.
    Gala K; Li Q; Sinha A; Razavi P; Dorso M; Sanchez-Vega F; Chung YR; Hendrickson R; Hsieh JJ; Berger M; Schultz N; Pastore A; Abdel-Wahab O; Chandarlapaty S
    Oncogene; 2018 Aug; 37(34):4692-4710. PubMed ID: 29755131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a multi-target compound for estrogen receptor-positive (ER
    Almeida CF; Teixeira N; Oliveira A; Augusto TV; Correia-da-Silva G; Ramos MJ; Fernandes PA; Amaral C
    Biochimie; 2021 Feb; 181():65-76. PubMed ID: 33278557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.
    Felzen V; Hiebel C; Koziollek-Drechsler I; Reißig S; Wolfrum U; Kögel D; Brandts C; Behl C; Morawe T
    Cell Death Dis; 2015 Jul; 6(7):e1812. PubMed ID: 26158518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
    O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
    Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancer.
    Wang S; Luo H; Wang C; Sun H; Sun G; Sun N; Zeng K; Song H; Zou R; Zhou T; Cong R; Liu W; Yang L; Li D; Zhou X; Zhong X; Lin L; Jiao J; Yan G; Wang X; Min X; Cao L; Zhao Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1615-1628. PubMed ID: 28216286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression.
    Zhang B; Zhang X; Tang B; Zheng P; Zhang Y
    Breast Cancer Res Treat; 2012 Nov; 136(2):399-406. PubMed ID: 23053650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardin inhibits estrogen receptor alpha-mediated proliferation of human breast cancer MCF-7 cells via regulating MicroRNA expression.
    Xiang Y; Lu DL; Li JP; Yu CX; Zheng DL; Huang X; Wang ZY; Hu P; Liao XH; Zhang TC
    IUBMB Life; 2016 Jun; 68(6):477-87. PubMed ID: 27156566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BCAS2 Enhances Carcinogenic Effects of Estrogen Receptor Alpha in Breast Cancer Cells.
    Salmerón-Hernández Á; Noriega-Reyes MY; Jordan A; Baranda-Avila N; Langley E
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogenically regulated LRP16 interacts with estrogen receptor alpha and enhances the receptor's transcriptional activity.
    Han WD; Zhao YL; Meng YG; Zang L; Wu ZQ; Li Q; Si YL; Huang K; Ba JM; Morinaga H; Nomura M; Mu YM
    Endocr Relat Cancer; 2007 Sep; 14(3):741-53. PubMed ID: 17914104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.